Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Mold-Tek Packaging Ltd
| Statement of Audited Financial Results for the Quarter & Year Ended 31 March, 2026
Report Source
⬤11th May 26
Summary : Mold-Tek Packaging reported strong FY26 growth, driven by operational efficiency and segment performance, with positive outlook.
Quarterly Report Analysis & Insights
Financial Disclosures
- Cost of materials consumed: 48451.49 lakhs (FY26).
- Employee benefits expense: 7584.95 lakhs (FY26).
- Finance costs: 1752.54 lakhs (FY26).
- Depreciation and amortization expenses: 5922.24 lakhs (FY26).
- Revenue from operations: 88660.95 lakhs for FY26 (13.48% Y-o-Y growth).
- Pharma Packs volume growth: 208.96%.
- FMCG Packs volume growth: 18.04%.
- Q-Packs volume growth: 25.82%.
- Paint Packs volume growth: 14.41%.
- Lubes Packs volume decline: 12.99%.
- Net cash inflow from operating activities: 12536.64 lakhs (FY26).
- Net cash outflow from investing activities: (13352.82) lakhs (FY26).
- Net cash inflow from financing activities: 783.44 lakhs (FY26).
- Total Assets: 105822.17 lakhs (FY26).
- Equity share capital: 1661.59 lakhs (FY26).
- Other equity: 67336.55 lakhs (FY26).
- Non-current borrowings: 7412.19 lakhs (FY26).
- Trade receivables: 17578.08 lakhs (FY26).
- Not explicitly specified, likely standalone results.
Corporate Overview
- Operates across India with 10 manufacturing units and 2 stock points.
- Manufacturing facilities in Hyderabad, Panipat (Haryana), Satara (Maharashtra), Cheyyar (Tamil Nadu).
- New factory building under construction at Mahad.
- Steep increase in raw material prices due to West Asia war.
- Volume decline in the Lubes Packs segment by 12.99%.
- Reliance on raw materials, susceptible to price increases.
- Manufacturer of injection moulded rigid plastic packaging solutions.
- Pioneer in innovative packaging technologies, including In-Mold Labeling (IML).
- Backward integrated, designing and manufacturing own robotic systems and IML labels.
- Confident about continued growth trajectory in FY 2026-27.
- Optimistic about crossing a turnover of Rs. 1,000 crores during FY 2026-27.
- Highlights strong operational performance and healthy revenue growth.
- Serves diverse industries including Lubricants, Paints, Food & FMCG, and Pharmaceuticals.
- Caters to reputed brands across various sectors.
- New orders from Aadharsh Chemicals, Coromandel Internal, Anatha Food, Even Hub, Jhansi Unit RSOL (food industry) and DifGen Pharmaceuticals Pvt Ltd (pharma sector).
- Lubricants packaging
- Paints packaging
- Food & FMCG packaging
- Pharmaceuticals packaging
- Pharma Packs
- FMCG Packs
- Q-Packs
- Paint Packs
- Lubes Packs
- Installed injection moulding capacity of over 63,000 TPA.
- Added 28 CRC assembling machines and an IBM machine.
- Plans to expand pharma packaging capacity with a wider range of products.
- 50% construction completed for a new factory building at Mahad.
- Increased production capacity at Panipat, Satara, and Cheyyar.
- Strengthened printing infrastructure by adding new offset printing machines, with one more planned by August 2026.
Risk Factors
- Raw material price increase due to war.
- Lubes Packs segment volume declined.
- Impact of new Labour Codes.
Key Drivers
- Strong EBITDA growth of 20.59%.
- PAT increased by 20.35% year-on-year.
- Pharma segment volume growth 208.96%.
- Targeting 1,000 crores turnover FY27.
Auditor’s Report
- Unmodified opinion on the Audited Financial Statements.
Board Commentary
- Declared and paid an Interim Equity Dividend of 40% (Rs. 2.00/- per equity share) for FY 2025-26.
- Government of India notified four new Labour Codes (Code on Wages, Industrial Relations Code, Code on Social Security, Occupational Safety, Health and Working Conditions Code).
- Company is restructuring employee compensation and assessing financial impact due to changes in regulations from Labour Codes.
- Investment in 28 CRC assembling machines and an IBM machine.
- Ongoing construction of a new factory building at Mahad (50% completed).
- Increased production capacity at Panipat, Satara, and Cheyyar.
- Investment in new offset printing machines.
Management Discussion & Analysis
Future Strategy
- Aims to continue growth trajectory in FY 2026-27.
- Targeting a turnover of Rs. 1,000 crores during FY 2026-27.
- Focus on product innovation and cost optimization for sustainable growth.
Industry Overview
- Strong traction in the pharmaceutical packaging sector due to focus on quality-driven and compliant solutions.
- Increasing customer acceptance and rising demand from pharmaceutical and healthcare sectors.
Macroeconomic Outlook
- Impact of West Asia war leading to steep increase in raw material prices.
Operational Focus Areas
- Strategic consolidation of manufacturing operations in Hyderabad for efficiency and cost optimization.
- Enhancing customer service and coordination across operations.
- Improving printing capacity and production planning flexibility.
Performance Drivers
- Improved operational performance leading to strong EBITDA growth.
- Healthy revenue and PAT growth.
- Strong demand across key business segments, particularly Pharma Packs (208.96% volume growth), FMCG Packs (18.04%), Q-Packs (25.82%), and Paint Packs (14.41%).
- Strategic consolidation of Hyderabad units improving operational efficiency and capacity utilization.
Risk Control Measures
- Successfully convinced clients for quicker and full absorption of price hikes.
Critical Risks
- Raw material price volatility due to geopolitical events.
- Segment-specific volume declines (e.g., Lubes Packs).